For Southeast Asian manufacturers considering the European market, understanding the regulatory framework is the first critical step. The EU Medical Device Regulation (MDR) 2017/745, which became fully applicable on May 26, 2021, represents a fundamental transformation from the previous directive-based system. Unlike directives that required transposition into national law (leading to inconsistencies across member states), the MDR is directly applicable in all EU member states without national transposition, ensuring uniform requirements across the single market [1].
The transition from MDD to MDR is not merely an incremental update. The regulation introduced strengthened requirements for clinical evidence, expanded post-market surveillance obligations, a new risk-based classification system with 22 classification rules (compared to 18 under MDD), more rigorous scrutiny of high-risk devices through the Article 54 scrutiny procedure, enhanced traceability through the Unique Device Identification (UDI) system, and the establishment of EUDAMED as the central European database for medical devices [1]. For manufacturers, this means CE marking under MDR demands a substantially greater investment in documentation, clinical evidence, and ongoing compliance compared to the former MDD framework.
Wrist support products occupy an interesting regulatory space. Depending on their intended purpose and design characteristics, they may be classified as Class I (lowest risk), Class IIa (moderate risk), or potentially higher. Class I devices are generally non-invasive, non-active devices with low risk, such as examination gloves or wound dressings without medicinal substances. However, if a wrist support incorporates stainless steel stabilizers intended for therapeutic purposes (such as carpal tunnel syndrome management or post-injury stabilization), the classification may shift to Class IIa or higher based on the duration of contact with the body and the degree of invasiveness [1].
"CE marking on a medical device is far more than a regulatory stamp or a logo affixed to packaging. It is a legal declaration by the manufacturer that the device conforms to all applicable requirements of the EU Medical Device Regulation (MDR) 2017/745, that the appropriate conformity assessment procedure has been carried out, and that the device is fit to be placed on the European market." [1]

